Conference on beta-thalassemia and healthcare innovation in Cyprus

On September 23, 2026, a press conference was held in Nicosia to address the ongoing challenge of beta-thalassemia, a condition affecting one in seven Cypriots. The event, organized by the biopharmaceutical company Bristol Myers Squibb, focused on recent scientific advancements, therapeutic options for myelodysplastic syndromes, and the necessity of institutional collaboration to ensure patient access to innovation.

Representatives from the medical, academic, and patient communities attended the meeting, alongside state officials including Maria Adamou from the Ministry of Health and Ifigeneia Kammitsi from the Health Insurance Organization (HIO). Dr. Sotiroula Christou of the Archbishop Makarios III Hospital and Dr. Niki Viridou presented new clinical data regarding disease management. Given the high carrier prevalence on the island, authorities emphasized the importance of consistent screening programs and public awareness to mitigate the impact of this hereditary disorder.